Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Mohammadreza Alivand

20PUBLICATIONS

23CO-AUTHORS

Molecular targetsCancer geneticsAtomic and molecular physicsCancer cell biologyMicrobial genetics

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (20)

Sort by Publication Date:

|Jan 25, 2022

The contributing factors of resistance or sensitivity to epigenetic drugs in the treatment of AML.

Shohre Karimi Kelaye, Fatemeh Najafi, Bahareh Kazemi

|Nov 19, 2021

Mucosa-Associated <i>Escherichia coli</i> in Colorectal Cancer Patients and Control Subjects: Variations in the Prevalence and Attributing Features.

Roghayeh Nouri, Alka Hasani, Kourosh Masnadi Shirazi

|Sep 12, 2021

The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update.

Zahra Torki, Davood Ghavi, Solmaz Hashemi

|Aug 30, 2021

The Effect of ω3 Fatty Acids Supplementation on Levels of PPARγ and UCP2 Genes Expression, Serum Level of UCP2 Protein, Metabolic Status, and Appetite in Elite male Athletes: Protocol for a Randomized Control Trial.

Sara Moradi, Mohamadreza Alivand, Yaser KhajeBishak

|Jul 08, 2021

The expression of miR-513c and miR-3163 was downregulated in tumor tissues compared with normal adjacent tissue of patients with breast cancer.

Soheila Delgir, Khandan Ilkhani, Asma Safi

|Apr 24, 2020

microRNAs involved in T-cell development, selection, activation, and hemostasis.

Behnam Emamgolizadeh Gurt Tapeh, Bashir Mosayyebi, Mahdieh Samei

Pageof 4

Frequent Collaborators

4 joint publications

Saeed Solali

2 joint publications

Yaser KhajeBishak

2 joint publications

Mahmoud Shekari Khaniani

1 joint publications

Sara Moradi

1 joint publications

Mohamad AsghariJafarabadi

1 joint publications

Amirhosien Faghfouri

1 joint publications

Beitullah Alipour

1 joint publications

Shahriar Alipour

1 joint publications

Maryam Abtin

1 joint publications

Sima M Derakhshan

Frequent Collaborators

4 joint publications

Saeed Solali

2 joint publications

Yaser KhajeBishak

2 joint publications

Mahmoud Shekari Khaniani

1 joint publications

Sara Moradi

Top Related Videos

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on : Jun 17, 2022

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on : Jul 28, 2010

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

See more related videos

Top Related Videos

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on : Jun 17, 2022

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on : Jul 28, 2010

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

See more related videos